Valuation : Kuros Biosciences AG

Market Cap 750M 924M 797M 683M 1.28B 87.7B 1.29B 8.86B 3.45B 44.61B 3.47B 3.39B 148B P/E 2026 *
91.6x
P/E 2027 * 39.3x
Enterprise Value 739M 911M 786M 673M 1.27B 86.45B 1.27B 8.74B 3.4B 43.97B 3.42B 3.35B 146B EV / Sales 2026 *
4.44x
EV / Sales 2027 * 3.17x
Free-Float
68.55%
Yield 2026 *
-
Yield 2027 * -
1 day-3.57%
1 week-11.76%
Current month-3.57%
1 month-16.59%
3 months-2.07%
6 months-30.16%
Current year-31.22%
1 week 18.83
Extreme 18.83
21.9
1 month 18.83
Extreme 18.83
23.9
Current year 17.69
Extreme 17.69
30.3
1 year 17.69
Extreme 17.69
34.2
3 years 1.76
Extreme 1.755
34.2
5 years 1.11
Extreme 1.11
34.2
10 years 1.11
Extreme 1.11
34.2
Manager TitleAgeSince
Chief Executive Officer 56 2023-10-11
Chief Executive Officer 60 2017-12-03
Director of Finance/CFO - 2023-02-16
Director TitleAgeSince
Chairman 69 2018-06-13
Director/Board Member 60 2018-06-13
Director/Board Member 57 2018-06-13
Date Insider Type Main position Quantity % Market Cap. Importance
5/26/26 Sell -7,225 0.0184%
12/13/25 Sell 30,000 0.0766%
12/8/25 Sell 30,000 0.0766%
Change 5-day change 1-year change 3-year change Capi.($)
-3.57%-11.76%-24.40%+894.74% 962M
-0.25%-0.92%+49.47%+89.45% 68.13B
+1.21%+0.80%+46.29%+85.32% 63.6B
+1.31%-5.21%+37.52%+12.07% 25.57B
-0.25%-1.92%-10.72%+436.70% 26.6B
+0.33%-10.61%+1.95%-16.27% 25.52B
-6.09%-12.08%+226.11%+375.00% 18.23B
+1.18%-2.23%+30.87%-19.04% 19.69B
-1.49%-6.44%+0.78%+540.26% 15.16B
+4.12%+0.30%+52.03%+150.18% 13.54B
Average -0.35%-4.20%+40.99%+254.84% 27.7B
Weighted average by Cap. +0.13%-2.89%+44.98%+146.49%

Financials

2026 *2027 *
Net sales 167M 205M 177M 152M 285M 19.49B 287M 1.97B 767M 9.91B 771M 754M 32.87B 224M 276M 238M 204M 383M 26.15B 385M 2.64B 1.03B 13.3B 1.03B 1.01B 44.11B
Net income 9.32M 11.49M 9.91M 8.49M 15.97M 1.09B 16.06M 110M 42.89M 555M 43.13M 42.2M 1.84B 21.65M 26.68M 23.02M 19.72M 37.09M 2.53B 37.29M 256M 99.62M 1.29B 100M 98.01M 4.27B
Net Debt -10.7M -13.18M -11.37M -9.74M -18.32M -1.25B -18.42M -126M -49.22M -636M -49.49M -48.42M -2.11B -41.26M -50.84M -43.86M -37.58M -70.68M -4.83B -71.06M -488M -190M -2.45B -191M -187M -8.14B
Logo Kuros Biosciences AG
Kuros Biosciences AG is a Switzerland‑based biotechnology company engaged in the research, development, and commercialization of biologic technologies for musculoskeletal care, with a focus on those supporting bone regeneration and bone growth. The Company's key product is MagnetOs, which is a synthetic bone graft technology available in multiple formats such as granules or putty. MagnetOs is designed to stimulate bone formation, including through mechanisms that engage the body’s immune response. The technology behind MagnetOs is associated with osteoimmunology, which involves immune‑modulated bone healing. MagnetOs uses the proprietary NeedleGrip submicron surface technology, which supports bone growth by enhancing biological responses related to healing. It is indicated for use across the skeletal system and is positioned as a bone graft option for procedures involving various anatomical regions.
Employees
178
Date Price Change Volume
26-09-01 CHF 18.90 -3.57% 435,276
26-08-31 CHF 19.60 -7.37% 354,352
26-08-28 CHF 21.16 -2.40% 88,809
26-08-27 CHF 21.68 +2.07% 131,856
26-08-26 CHF 21.24 -0.84% 127,228
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
18.90CHF
Average target price
33.92CHF
Spread / Average Target
+79.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. KURN Stock